Bristol-Myers Squibb (BMY)

$78.96 1.27 (1.63%)

19:00 EDT BMY Stock Quote Delayed 30 Minutes

7 Blue-Chip Stocks With Strong Dividend Yields

By Alex Sirois Jun 9, 2022

Blue-Chip stocks are particularly attractive in volatile times like now. These picks include a strong dividend as well.

7 Cheap Growth Stocks That Won’t Stay That Way for Long

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

The Top 10 Stocks Helping Warren Buffett Beat the Market

Volume:

Previous Close -

Market Cap 175.46B

PE Ratio 28.00

EPS 2.82

Volume (Avg. Vol.) 12.37M

Day's Range $78.12 - $79.00

52-Week Range $53.22 - $79.00

Dividend & Yield $1.96 (2.48%)

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

From InvestorPlace
From the Web

3 Recession-Proof Dividend Stocks to Buy

By Bob Ciura, Sure Dividend Apr 8, 2022

ABM Industries, Bristol-Myers and UGI are three examples of companies that saw earnings-per-share grow by high rates during the 2007 to 2009 period. All three companies have extensive dividend growth track records and each stock yields higher than what the S&P 500 is paying.

Best Stocks for 2022: Bristol-Myers Squibb Isn’t Done Growing

By Sure Dividend Apr 8, 2022

It's been a great year for Bristol-Myers Squibb this year, but it's not too late to jump in. BMY stock offers a respectable dividend.

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline Apr 5, 2022

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

7 No-Brainer Stocks to Buy for April

By Chris Lau, InvestorPlace Contributor Apr 4, 2022

Start your stock scan with companies showing strong quant scores in value, growth and quality, then buy those with strong catalysts.

7 Michael Burry Stocks to Buy as ‘The Big Short’ Investor Makes Moves

By Thomas Niel Mar 17, 2022

So, which names now make up the Michael Burry stocks? Let's dive in, and check out these seven, the six that are U.S.-based, plus one foreign stock you can buy over-the-counter (OTC): Bristol-Myers Squibb (NYSE:BMY) CoreCivic (NYSE:CXW) Fidelity National Financial (NYSE:FNF) General Dynamics (NYSE:GD) Geo Group (NYSE:GEO) Imperial Brands (OTCMKTS:IMBBY) AEA-Bridges Impact (NYSE:IMPX)

3 Top Stock Trades for This Week

By Tyler Craig, Tales of a Technician Mar 15, 2022

Bulls seeking stock trades should focus on relative strength. Here are three stocks itching for new highs as the market sinks.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

8 Strong Uptrend Stocks to Buy on the Next Dip

By Bret Kenwell, InvestorPlace Contributor Mar 9, 2022

It's hard to believe, but there are uptrend stocks out there. Investors just have to look for the strength that these stocks are showing.

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Financial News Writer Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

3 Healthcare Stocks Ignoring the Market Mayhem

By Tyler Craig, Tales of a Technician Jan 19, 2022

Sellers dominate the Street this week, but some healthcare stocks remain unaffected. Here are three to put atop your watchlist.

10 Best Stocks for 2022: What’s on Tap for Wall Street This Year?

By Nick Clarkson, Web Editor Jan 14, 2022

With the new year underway on Wall Street, 10 InvestorPlace writers and analysts select their picks for the best stocks for 2022.

3 Top Stock Trades for the Week of Jan. 10, 2022

By Tyler Craig, Tales of a Technician Jan 10, 2022

Sellers continue to push their advantage making it necessary to play defense to win. Here are three top stock trades for the new week.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

Best Stocks for 2022: Bristol-Myers Squibb Will Offer Huge Returns

By Sure Dividend Dec 30, 2021

Bristol-Myers Squibb offers a substantial dividend, but that's far from the only reason that BMY stock is a great investment for 2022.

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

3 Cheap Healthcare Stocks to Buy Right Now

By David Cohne, StockNews.com Sep 22, 2021

The Baby Boomers are getting older, which means investors should consider adding undervalued healthcare stocks to their portfolio.

7 Stocks to Buy to Invest Like Jim Cramer

By Bret Kenwell, InvestorPlace Contributor Sep 16, 2021

Jim Cramer has done an excellent job exciting investors about stocks to buy. That said, let's look at some of his favorite picks.

7 Stocks to Buy if the Market Crashes in September

By Tezcan Gecgil, InvestorPlace Contributor Sep 13, 2021

Market crashes often present lucrative investment opportunities for investors in top stocks to buy at cheaper prices. Watch these seven.

7 Stocks To Buy To Bet on Underappreciated CEOs

By Will Ashworth, InvestorPlace Contributor Sep 10, 2021

We hear plenty of stories about overpaid CEOs. Here are seven stocks to buy whose CEOs aren’t but still manage to deliver for shareholders.

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

From Benzinga May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology

From Benzinga May 12, 2022

BANKRUPTCY WATCH

Bristol-Myers Squibb (BMY)

7 Blue-Chip Stocks With Strong Dividend Yields

7 Cheap Growth Stocks That Won’t Stay That Way for Long

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

The Top 10 Stocks Helping Warren Buffett Beat the Market

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BANKRUPTCY WATCH

Bristol-Myers Squibb (BMY)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BMY Stock Predictions, Articles, and Bristol-Myers Squibb News

Subscriber Sign in